logo
mesalazine in ulcerative colitis – is it time to revise treatment guidelines in the UK?
mode of action and delivery of 5-aminosalicylic acid – new evidence
induction therapy for patients with active ulcerative colitis
maintenance therapy in patients with ulcerative colitis